Frequent incidences of heavy metal poisoning owing to environmental pollution and industrialization has led to increased demand for advanced studies in heavy metal poisoning (toxicology).

This report presents detailed insights on the impact of recent trends and developments on the growth of the market.

Chelation Therapy Has Aided Heavy Metal Poisoning Treatment
Leading companies and institutions across the globe are implementing methods to fulfill the need of advanced studies in therapeutics pertaining to toxicology. Chelation therapy is a dedicated field of medication used to treat heavy metal poisoning triggered by mercury and lead.

To meet the medical concerns of end-users, drug manufacturers are incorporating novel features to improve the effectiveness of drugs and chelating agents used in chelation therapy. Manufacturers include powerful chelating agents such as Dimercaptosuccinic Acid (DMCA), Alpha Lipoic Acid (ALA), Ethylenediaminetetraacetic Acid (EDTA), penicillamine, and bismuth subnitrate to ensure superior treatment results of chelation therapy.

In order to eliminate side-effects of the procedure, companies are incorporating new elements without compromising on the effectiveness of the therapy. Introduction of transdermal version of DMCA has proved to reduce gastrointestinal side effects, thus making it suitable to treat pediatric cases of metal poisoning.

Further, manufacturers have also improved the route of drug administration to benefit end-users with quick and effective treatment procedures. For instance, antioxidants such as ALA and N-acetylcysteine have been made available as nasal spray and oral solution in order to enhance recovery of the end-user. Administering such innovative techniques has aided manufacturers to retain their position in the market.

Vital inferences compiled in the report presents valuable insights related to the influence of growth of various segments in the market. In this section, the report highlights vital segments of the market which include therapeutics assessment and drug profile. Based on therapeutics assessment, the market is segmented as assessment by target, assessment by mechanism of action, route of administration, and molecule type. Based on drug profile the market is segmented as deferasirox, deferoxamine mesylate, emeramide, hinokitiol, LJPC-401, NU-02, PDX-003, and Zn-DTPA. On the basis of inferences portrayed in the report, readers can comprehend and identify the segments that are contributing extensively towards revenue generation and the impact of the same on the growth of the market. The report also presents sufficient insights that can aid leading companies and new entrants can understand the strategies better and formulate accurate business decisions to fetch maximum profits.

Key Players Identified in Heavy Metals Poisoning Market

Significant insights compiled in the report provides vital information on various strategies and policies followed by leading companies and its influence on the customer’s purchase decisions. Based on the perspectives encapsulated in the report, leading firms and new market players can make accurate analysis and important investment decisions. Leading companies operating in the global market include La Jolla Pharmaceutical Company, Medesis Pharma SA, PDX Pharmaceuticals LLC among others.